Optimizing CRISPR/Cas9 genome editing in primary human hematopoietic cells to advance studies into HIV biology

Hong-Ru Chen N. Kadzioch Madeleine Gapp Hsiu-Hui Yang A. Ruhle Javier Villamizar Cujar Thimo Fuchs Niklas A. Schmacke Veit Hornung R. Speck O. Keppler M. Albanese

Aug 2026 · bioRxiv · 0 citations · 29 references

Biology

DOI Semantic Scholar

View source

Similar papers

#gene editing Open access Aug 2026

Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells.

A virus-like particle (VLP)-based toolkit that delivers diverse CRISPR editing modalities to human monocytes, macrophages and dendritic cells with high efficiency while preserving viability and innate immune responsiveness is presented.

Hyuncheol Jung, Pascal Devant, Carter Ching et al. · Nature Biotechnology · 0 citations

Open access Jul 2026

CD4-directed nanoblades enable selective genome editing in CD4+ cells and HIV suppression in vitro and in vivo

A proof-of-concept study supports the promise of CD4-NBs as a minimally invasive, CD4⁺ cell-targeted gene editing strategy for HIV therapy and reduces viremia in ART-pretreated humanized mice.

Jolien Van Cleemput, Maaike De Cock, R. Verbeek et al. · EMBO Molecular Medicine · 0 citations

#gene editing Open access Aug 2026

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factors

Lipofection- and lentivirus-mediated protocols for CRISPR-Cas9 delivery in mouse-passaged primary human hepatocytes (mpPHH) are reported, a system that enables PHH expansion in liver-humanized mice and enables scalable genetic manipulation of mpPHH, opening new avenues for HBV research and liver disease modeling.

Ansgar F. Stenzel, Antonis Athanasiadis, Georgios Dangas et al. · bioRxiv · 0 citations

Open access Aug 2026

CRISPR/Cas9-based repair of a heterozygous HNF1A mutation in patient-derived hiPSCs

Human induced pluripotent stem cells (hiPSCs) represent a powerful platform for disease modeling, especially in monogenic diseases as they preserve the donor’s genetic background while enabling directed differentiation into disease-relevant cell types. This makes them highly suitable for studying disease mechanisms in...

D. Skoczek, J. Hohendorff, Maciej T. Małecki et al. · Human Genetics · 0 citations

Jul 2026

Efficient CRISPR/Cas9-mediated homology independent sequence replacement in vivo and non-dividing primary cells

REPLACE is established as a versatile platform for homology-independent sequence replacement and as a complementary approach for genetic correction in settings where homology-directed repair (HDR), base editing (BE) or prime editing (PE) are inefficient or not applicable.

Tu Dang, Alexandra Roman, Anja Zimmer et al. · bioRxiv · 0 citations

Open access Jul 2026

Base Editing Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of X-Linked Severe Combined Immunodeficiency

It is concluded from preliminary data that gene therapy using BE HSPCs appear very promising for achieving an earlier and more robust multi-lineage immune reconstitution in adult patients using BE HSPCs.

S. S. de Ravin, Michelle Ma, Yuzhi Yin et al. · Journal of Human Immunity · 0 citations